J&J | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Abbott USD 25.12B 28M 2025-03
Amgen USD 33.58B 45M 2025-03
AstraZeneca USD 1.55B 1.16B 2025-06
Baxter International USD 683M 0 2024-12
Bayer EUR 2.52B 0 2025-03
Becton, Dickinson and Co. USD 371M 0 2025-03
Biogen USD 146.6M 146.5M 2025-06
Boston Scientific USD 17M 0 2025-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
CONMED USD 30.95M 30.63M 2025-06
Cooper Companies USD 21.8M 100K 2025-04
Dexcom USD 392.2M 391.8M 2025-06
Edwards Lifesciences USD 654.8M 500K 2024-12
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Globus Medical USD 135K 2K 2025-03
Hologic USD 222.22M 219.22M 2025-06
Insulet USD 100K 0 2025-03
Integra LifeSciences USD 77.92M 77M 2025-06
Intuitive Surgical USD 358.42M 358.02M 2025-06
J&J USD 3.12B 0 2025-03
Medtronic USD 128K 128K 2025-04
Merck USD 1.79B 0 2025-03
Merit Medical Systems USD 59.22M 658.89M 2025-06
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
Stryker USD 382.3M 344.3M 2025-06
Tandem Diabetes Care USD 67K 1000 2025-03
Teva Pharmaceutical Industries USD 1.15B 1.09B 2025-06
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Zimmer Biomet Holdings USD 3.2M 0 2024-12
Zoetis USD 5M 0 2025-03


J&J Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.